Burgundy Asset Management Ltd. Has $115.49 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Burgundy Asset Management Ltd. lowered its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,668,899 shares of the company's stock after selling 167,353 shares during the quarter. Burgundy Asset Management Ltd. owned about 1.34% of Henry Schein worth $115,488,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Venturi Wealth Management LLC raised its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC raised its stake in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the period. Allworth Financial LP grew its position in Henry Schein by 180.7% in the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after buying an additional 609 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan bought a new position in Henry Schein in the 4th quarter valued at about $95,000. Institutional investors own 96.62% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Barrington Research reduced their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Wells Fargo & Company decreased their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Finally, Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Trading Down 0.1%

Shares of HSIC stock traded down $0.06 during trading hours on Wednesday, reaching $73.61. 254,511 shares of the stock traded hands, compared to its average volume of 1,657,600. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.96 billion, a PE ratio of 30.28, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The business has a fifty day moving average price of $67.54 and a 200 day moving average price of $71.58.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.10 earnings per share. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Activity

In other news, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.